pegfilgrastim anti-neutropenic factor
Term · Oncology and biomedicine · MLC-T-ONC-015907
A long-acting, engineered and pegylated version of human granulocyte-colony stimulating factor (G-CSF), with potential hematopoietic activity. Similar to G-CSF, pegfilgrastim anti-neutropenic factor (ANF) binds to and activates specific cell surface receptors, and stimulates neutrophil progenitor proliferation and differentiation. Therefore, this agent may prevent the duration and incidence of chemotherapy-induced neutropenia. Compared to filgrastim, the conjugation with a branched polyethylene glycol molecule reduces renal clearance and increases its plasma half-life.
| Identifier | MLC-T-ONC-015907 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | PEG G-CSF ANF; pegfilgrastim ANF |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015907",
"term": "pegfilgrastim anti-neutropenic factor",
"field": "Oncology and biomedicine",
"definition": "A long-acting, engineered and pegylated version of human granulocyte-colony stimulating factor (G-CSF), with potential hematopoietic activity. Similar to G-CSF, pegfilgrastim anti-neutropenic factor (ANF) binds to and activates specific cell surface receptors, and stimulates neutrophil progenitor proliferation and differentiation. Therefore, this agent may prevent the duration and incidence of chemotherapy-induced neutropenia. Compared to filgrastim, the conjugation with a branched polyethylene glycol molecule reduces renal clearance and increases its plasma half-life.",
"synonyms": [
"PEG G-CSF ANF",
"pegfilgrastim ANF"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/pegfilgrastim-anti-neutropenic-factor/"
}
Record 12,846 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.